
GC34072
Talmapimod
Also listed as Talmapimod (SCIO-469)
Talmapimod (SCIO-469) (SCIO-469) is an orally active, selective, and ATP-competitive p38α inhibitor with an IC50 of 9 nM· Talmapimod (SCIO-469) shows about 10-fold selectivity over p38β, and at least 2000-fold selectivity over a panel of 20 other kinases, including other MAPKs
ChemicalCAS309913-83-5MW513FormulaC27H30ClFN4O3
- CAS number
- 309913-83-5
- Molecular weight
- 513
- Formula
- C27H30ClFN4O3
- Solubility
- DMSO : ≥ 100 mg/mL (194·93 mM)
- InChIKey
- ZMELOYOKMZBMRB-DLBZAZTESA-N
- Catalogue number
- GC34072
- Brand
- GLPBIO
Computed properties PubChem CID 9871074 · XLogP 3.7 · TPSA 65.9 Ų · H-bond donors 0
- XLogP
- 3.7
- TPSA
- 65.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 36
SMILES C[C@@H]1CN([C@H](CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F
Computed descriptors from PubChem (CID 9871074), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il